A detailed history of China Universal Asset Management Co., Ltd. transactions in Viatris Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 228,272 shares of VTRS stock, worth $2.37 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
228,272
Previous 228,272 -0.0%
Holding current value
$2.37 Million
Previous $2.73 Million 0.04%
% of portfolio
0.35%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$11.27 - $13.53 $1.01 Million - $1.21 Million
89,501 Added 64.5%
228,272 $2.73 Million
Q4 2023

May 21, 2024

SELL
$8.77 - $10.85 $784,923 - $971,085
-89,501 Reduced 39.21%
138,771 $1.5 Million
Q4 2023

Jan 23, 2024

BUY
$8.77 - $10.85 $947,028 - $1.17 Million
107,985 Added 350.76%
138,771 $1.5 Million
Q3 2023

May 21, 2024

BUY
$9.59 - $11.35 $144,530 - $171,055
15,071 Added 95.9%
30,786 $303,000
Q3 2023

Oct 30, 2023

BUY
$9.59 - $11.35 $144,530 - $171,055
15,071 Added 95.9%
30,786 $304,000
Q2 2023

May 21, 2024

SELL
$9.02 - $10.29 $4,519 - $5,155
-501 Reduced 3.09%
15,715 $156,000
Q2 2023

Jul 27, 2023

SELL
$9.02 - $10.29 $4,519 - $5,155
-501 Reduced 3.09%
15,715 $157,000
Q1 2023

May 21, 2024

BUY
$9.2 - $12.26 $35,843 - $47,764
3,896 Added 31.62%
16,216 $155,000
Q1 2023

Apr 27, 2023

BUY
$9.2 - $12.26 $35,843 - $47,764
3,896 Added 31.62%
16,216 $156,000
Q4 2022

May 21, 2024

SELL
$8.72 - $11.56 $1.88 Million - $2.5 Million
-215,952 Reduced 94.6%
12,320 $137,000
Q4 2022

Jan 31, 2023

BUY
$8.72 - $11.56 $8,414 - $11,155
965 Added 8.5%
12,320 $137,000
Q3 2022

Oct 21, 2022

BUY
$8.48 - $11.13 $96,290 - $126,381
11,355 New
11,355 $97,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.